Lingmin Lin

机构：Hangzhou First People's Hospital, First Affiliated Hospital Zhejiang University · ORCID：0000-0003-4798-5508

发表论文 16 篇 · 总被引 355 次 · h-index 6

代表论文

• Porous microneedle patch with sustained delivery of extracellular vesicles mitigates severe spinal cord injury (2023 · Nature Communications · 被引 119)
• Controlled delivery of a neurotransmitter–agonist conjugate for functional recovery after severe spinal cord injury (2023 · Nature Nanotechnology · 被引 95)
• An engineering-reinforced extracellular vesicle–integrated hydrogel with an ROS-responsive release pattern mitigates spinal cord injury (2025 · Science Advances · 被引 75)
• ROS filter coating scaffold protects 3D mesenchymal stem cell spheroids for dual-phase treatment of spinal cord injury (2023 · Chemical Engineering Journal · 被引 24)
• A biocompatible two-photon absorbing fluorescent mitochondrial probe for deep in vivo bioimaging (2021 · Journal of Materials Chemistry B · 被引 15)
• Association of Fibroblast Growth Factor 23 With Ischemic Stroke and Its Subtypes: A Mendelian Randomization Study (2020 · Frontiers in Genetics · 被引 12)